600196 复星医药
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
2020/12
人民币(K¥)
2019/12
人民币(K¥)
经营活动产生之现金流量净额3,414,2174,217,5713,937,8152,579,7743,222,413
投资活动产生之现金流量净额(3,819,290)(4,064,038)(3,857,489)(4,706,229)(171,963)
筹资活动产生之现金流量净额(1,336,250)4,428,475(819,407)1,467,129(1,935,978)
汇率变动对现金及现金等价物的影响73,645128,342(134,712)(300,165)(5,105)
现金及现金等价物净增加/(减少)(1,667,678)4,710,350(873,794)(959,490)1,109,366
期初现金及现金等价物余额11,170,0676,459,7177,333,5118,284,3717,175,005
期末现金及现金等价物余额9,502,38911,170,0676,459,7177,324,8818,284,371